"/> Invitrogen™ Peptide synthétique JMJD7 humain | B-LABO France

Invitrogen™ Peptide synthétique JMJD7 humain

Réf. : BL-RE-176302Réf. fabricant : 15309170 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
100137047
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
P0C870
Nom usuel
Human JMJD7
Marque
Invitrogen

JMJD7 Synthetic Peptide, PEP-0923, from Invitrogen.

The jumonji domain-containing protein (JMJD) family is defined by the presence of the JmjC domain that is observed in several diverse species. While several JMJD proteins have been identified as being involved in chromatin regulation, histone demethylation and development, the function of JMJD7 has not been identified. JMJD7 was initially thought to be a novel splice form of the phospholipase PLA2G4B which is located downstream of JMJD7 as most tissues express a read-through transcript of the two genes.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176302
Réf. fabricant15309170
Gene ID (Entrez)100137047
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionP0C870
Nom usuelHuman JMJD7
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)JMJD7
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.